|
Company name | Wyeth | Company type | Subsidiary | Industry | Pharmaceuticals, Healthcare | Founded | (1860) Philadelphia, Pennsylvania, U.S. | Headquarters | Madison, New Jersey, | Key people | Bernard J. Poussot, CEO, President and Vice Chairman of Wyeth Robert Essner, Chairman Joseph Mahady, President, Global Business, Wyeth Pharmaceuticals John Wyeth, Founder | Products | Premarin, Effexor, Enbrel, (See more products.) | Revenue | (+) US$ 22.40 billion (2008) | Net income | (+) US$ 4.616 billion (2008) | Employees | 49,732 (2005) | Parent | Pfizer |
|
Wyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company. The company was based in Madison, New Jersey, USA. They were known for manufacturing the over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen), as well as the prescription drugs Premarin and Effexor, which both boast over US$3 billion in sales annually.
On January 23, 2009 The Wall Street Journal reported that Pfizer was in talks to buy Wyeth at a cost of US$68 billion. On January 25, Pfizer agreed to the purchase, a deal financed with cash, shares and loans. The deal was completed on October 15, 2009.
|
|
|